Clover Corp

Clover Corporation Limited is an Australian-based company specializing in the refinement and delivery of high-value specialty lipids, particularly Omega-3 and Omega-6 fatty acids. The company is best known for its proprietary Driphorm microencapsulation technology, which allows for the stable incorporation of nutritional oils into infant formula, beverages, and food products without compromising taste or shelf life. Clover's primary focus is the global infant formula market, where its docosahexaenoic acid (DHA) products support brain and eye development. Beyond nutrition, the company explores pharmaceutical applications for its lipid delivery systems, including treatments for respiratory conditions in preterm infants. Clover operates manufacturing facilities in Australia and maintains strategic partnerships for spray-drying capabilities in New Zealand.